Jiangxi Rimag Group (HKG:2522) is looking to raise net proceeds of up to HK$182.3 million from the placement of 9,750,000 shares to at least six investors at HK$20 apiece, a Friday filing with the Hong Kong bourse said.
The shares represent approximately 3.76% of issued H shares and 2.66% of the total number of issued shares as enlarged by the issue.
The medical imaging solution services company will use proceeds from the issue for business investment and mergers and acquisitions, overseas business expansion, data and R&D, and general working capital.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。